AbbVie: Remarkable 700% Return Potential Over Next Decade

Posted On August 20, 2018 8:02 am

Find out why my favorite high-yield blue chip pharma stock has everything that income investors could want. That includes: exceptional management, strong short and long-term growth catalysts, and a valuation from which it could easily generate 20% or greater annualized total returns over the coming years.

Continue Reading Here

Photo: “Money” by 401(K) 2013 is licensed under CC BY-SA

About author

Dividend Sensei
Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I currently write for both Seeking Alpha, Simply Safe Dividends, and DividendSensei.com My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 22 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams. I'm currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that: 1. Pays a 5% yield 2. Offers 7% annual dividend growth 3. Pays dividends AT LEAST on a weekly, but preferably, daily basis

Related Articles

Leave a reply

Your email address will not be published. Required fields are marked *